Metabolic research has advanced considerably over the past decade, revealing intricate enzyme pathways that govern energy balance, fat storage, and cellular aging. Among these discoveries, nicotinamide N-methyltransferase (NNMT) has emerged as a pivotal regulator of NAD+. Understanding why researchers gravitate toward 5 amino 1mq Peptide, this particular molecule reveals much about modern metabolic science. The compound's selectivity for NNMT, combined with its favorable cellular permeability and well-characterized mechanism, makes it indispensable for laboratories exploring fat metabolism, energy expenditure, and age-related metabolic decline. Research teams worldwide now employ this small-molecule inhibitor to unravel complex biochemical questions that were previously difficult to address.
1.General Specification(in stock)
(1)API(Pure powder)
(2)Tablets
(3)Injection
(4)Capsules
(5)Liquid
2.Customization:
We will negotiate individually, OEM/ODM, No brand, for secience researching only.
Internal Code:KP-3-5/002
NNMTi CAS 42464-96-0
Molecular formula: C10H11N2.I
HS code: N/A
Molecular weight: 286.11
EINECS number: 464-196-0
Main market: USA, Australia, Brazil, Japan, Germany, Indonesia, UK, New Zealand , Canada etc.
Analysis: HPLC, LC-MS, HNMR
Technology support: R&D Dept.-4
We provide 5-Amino-1MQ Peptide Injection, please refer to the following website for detailed specifications and product information.
Product:https://www.kpeptide.com/peptides-healthy/5-amino-1mq-peptide-injection.html
How Does 5 Amino 1MQ Peptide Work as an NNMT Inhibition Research Compound?
Molecular Structure and Selectivity Profile
+
-
The quinoline-based structure of the 5 amino 1mq peptide makes it very selective for the active sites of NNMT enzymes. Because of this, researchers can be sure that the effects they see are caused by NNMT suppression and not interactions with other molecules. The small size of the molecule makes it easy for cells to take it in quickly, so researchers can study how NNMT works inside cells without having to use complicated delivery methods.
Studies in the lab show that this compound's blocking effect stays the same on a wide range of cell types. When put on adipocyte cultures at doses between 10 and 50 μM, the inhibitor regularly lowers NNMT activity while keeping other methyltransferase functions the same. This selection is very important for figuring out what role NNMT plays in cellular metabolism without other factors getting in the way.
Mechanism of Action in Cellular Systems
+
-
Using S-adenosylmethionine as a methyl donor, NNMT speeds up the methylation of nicotinamide, creating 1-methylnicotinamide and reducing the active site of cellular NAD+. The 5 amino 1mq peptide stops substrate binding and methylation reactions. This blockade raises the amount of NAD+ inside cells.
Researchers use this compound to look into the metabolic effects that happen after NNMT inhibition. Treatment with the inhibitor during adipogenesis greatly decreases the formation of lipid droplets in studies of preadipocyte differentiation. A study of gene expression shows lower amounts of two important transcription factors that help fat cells mature: peroxisome proliferator-activated receptor gamma (PPARγ) and CCAAT/enhancer-binding protein alpha (C/EBPα). These findings help scientists figure out the molecular pathways that link NNMT activity to the growth of adipose tissue.
Pharmacological Properties Supporting Research Applications
+
-
The chemical properties of the substance fit well with the needs of the experiment. Because it dissolves easily in water, it's easier to make stock solutions and working amounts for studies with cell cultures. Stability in normal lab settings makes sure that results are the same across multiple trials and multi-day methods.
Researchers like that the inhibitor has effects that change with dose, which lets them make more accurate dose-response graphs. Scientists use this link between concentration and action to figure out the best treatment settings for different experimental systems. The substance also starts working pretty quickly, which lets scientists see its short-term effects on NNMT blocking. Long-term treatments, on the other hand, show how the metabolism changes over time.
Understanding NNMT Enzyme Activity Through 5 Amino 1MQ Peptide Studies
Enzyme characterisation studies are based on biochemical tests that measure NNMT activity. Researchers use the 5 amino 1mq peptide as a standard inhibitor to find out how enzymes work and make sure that the test systems are correct. Scientists figure out inhibition factors and study how enzymes interact with substrates by comparing enzyme activity when the inhibitor is present and when it is not.
These quantitative measurements have shown that NNMT expression and activity levels vary depending on the tissue. There are different NNMT patterns in adipose tissue, liver, and skeletal muscle that are related to how they work metabolically. The inhibitor is used as a reference in all of these studies, which makes it possible to make meaningful comparisons between different types of tissue and different experimental settings.
Mapping Metabolic Consequences of NNMT Activity
The connection between NNMT activity and NAD+ levels in cells. Metabolomic profiling studies that used this compound found changes in the metabolic network that go beyond NAD+'s role in larger metabolic frameworks. These findings support further research into it as a possible intervention target.
NNMT-dependent metabolic regulation is shown through time-course experiments using a 5 amino 1mq peptide. NAD+ is mostly affected by short-term treatments (hours). Researchers can tell the difference between direct NNMT effects and secondary changes with the help of these time studies. Understanding this timeline is important for coming up with intervention plans and figuring out what the results of an experiment mean. Because the compound stays active over long treatment periods, it is especially useful for long-term control trials.
5 Amino 1MQ Peptide Applications in Cellular Metabolic Enzyme Research
5 amino 1mq peptide is used a lot in adipogenesis research to look into NNMT's role in fat cell development. When the 3T3-L1 preadipocyte model is treated with differentiation medium that contains the inhibitor, triglyceride accumulation is much lower than in the vehicle controls. Quantitative PCR research shows that adipogenic transcription factors are not expressed as much, which shows that NNMT is involved in controlling transcription factors that control the formation of fat cells.
The chemical is used in lipolysis tests to look into how fat breaks down. When the inhibitor is added to adult adipocytes, it increases the production of hormone-sensitive lipase (HSL) and adipose triglyceride lipase (ATGL). These are two important enzymes that break down triglycerides. Glycerol release tests show that lipolysis activity has increased, which supports blocking NNMT as a way to help fat mobilisation. These experimental methods have helped us learn more about the metabolic processes that control how fat is stored and used.
Mitochondrial Function and Energy Expenditure Research
Another important area of study that has practical uses is mitochondrial bioenergetics. Researchers who treat cells with a 5 amino 1mq peptide see higher rates of oxygen use, which can be measured by Seahorse extracellular flux analysis. Higher respiration means that mitochondria can do more oxidative phosphorylation, which is linked to more NAD+.
Analysis of the expression levels of markers for mitochondrial formation shows that they go up after inhibitor treatment. Peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), which controls mitochondrial formation, is expressed more in cells that don't have NNMT. Quantification of mitochondrial DNA and electron imaging shows that the amount of mitochondria has actually grown, showing that blocking NNMT leads to mitochondrial growth.
Why NNMT Pathways Matter in 5 Amino 1MQ Peptide Investigation
Connecting NNMT to Metabolic Disease Models
Using animal models and the inhibitor, researchers have found links between NNMT activity and metabolic problems. Diet-induced obese rats that were given the 5 amino 1mq peptide gained less body weight, had less adipose tissue mass, and could handle glucose better than controls that were given a vehicle. These effects on the whole organism back up what we know about cells and biochemistry. They show that blocking NNMT has metabolic benefits that reach complex bodily systems.
Hepatic steatosis models show that blocking NNMT lowers the buildup of triglycerides in the liver and raises insulin sensitivity in the liver. In the livers of animals that were treated, researchers see less of lipogenic enzymes like fatty acid synthase (FAS) and acetyl-CoA carboxylase (ACC). At the same time, markers for fatty acid oxidation rise, showing a change from lipid production to oxidation. These findings show that NNMT is an important part of fatty liver disease.
Inflammatory Response and Metabolic Inflammation Research
Inflammation in adipose tissue plays a big role in metabolic problems linked to fat. Studies using a 5 amino 1mq peptide show that blocking NNMT lowers the production of inflammatory markers in fat tissue. Tumour necrosis factor-alpha (TNF-α) and interleukin-6 (IL-6) mRNA levels drop after treatment, and macrophages are less likely to enter fat depots.
Mechanistic studies show that blocking NNMT changes the signalling pathways that cause inflammation. NF-κB activation, a key inflammatory mediator, is slowed down in cells that don't have NNMT inhibition when they are exposed to inflammatory triggers. These results suggest that NNMT affects both metabolic and inflammatory processes. This makes it a potentially useful target for treating metabolic inflammation.
Aging Research and Metabolic Decline
As people get older, their metabolism slows down, and more NNMT is expressed in many organs. Scientists use the peptide inhibitor to see if changing this gene pattern can help slow down the metabolism changes that come with getting older. Research on old rats has shown that treatment improves physical ability, makes muscles stronger, and speeds up the healing process. Researchers studying cellular senescence use the substance to look into NNMT's role in cells that don't work properly as they age. Higher levels of NNMT are seen in senescent cells, while NAD+ levels are low.
Advancing Metabolism Research With 5 Amino 1MQ Peptide and NNMT Studies
More and more, researchers are looking into how NNMT inhibition can work with other metabolic interventions. When you combine 5 amino 1mq peptide treatment with calorie restriction, it makes it easier for animal models to lose weight and improve their metabolism. These combination studies help find the best ways to intervene and show how different metabolic control systems interact with each other.
Exercise studies show that NNMT inhibition and physical activity work hand-in-hand to improve muscle performance and energy use. The inhibitor improves the changes that exercise makes to the mitochondria, and exercise makes the metabolic benefits of NNMT inhibition even stronger. Understanding these relationships is important for making complete plans for metabolic management.
NNMT study is getting better all the time, thanks to new analytical methods. Using stable-labeled substrates and isotope tracking methods, scientists can get a much better idea of how metabolites move through NNMT-dependent pathways. Researchers can measure changes in pathway activity caused by NNMT inhibition when these methods are used with the specific inhibitor.
Single-cell analysis technologies show that NNMT expression and inhibitor responses are different in different cells. Not every cell in a tissue reacts the same way to treatment. Knowing this difference helps you figure out which groups of cells cause the effects you see. These scientific improvements help us learn more about how mechanisms work and find the cell targets that respond best to NNMT modulation.
A lot of experimental data was gathered using the 5 amino 1mq peptide, which helps with translational research. Animal studies that look at pharmacokinetics and safety set the dose factors and toxicity profiles that are needed for possible human development. There is still a lot of work to be done before the substance can be used on people, but its use in studies has made it possible for these next steps. Another area of focus for translational research is the development of biomarkers. Scientists are trying to find easy-to-measure signs of NNMT activity and inhibition in living things. These biomarkers would make it easier to track how well treatments are working and figure out which groups are most likely to benefit from NNMT-targeted interventions.
Conclusion
The 5 amino 1mq peptide is very important in metabolic studies because it has a unique mix of specificity, potency, and usefulness. Researchers have used this substance to figure out what part NNMT plays in many metabolic processes, such as the differentiation of adipocytes, the function of mitochondria, and the control of inflammation. As scientists learn more about how NNMT works, they can use this inhibitor in more and more research projects.
Metabolic science benefits a lot from having well-studied, selective tool compounds that let scientists ask precise questions about certain enzyme pathways. The peptide inhibitor is an example of this kind of tool because it gives researchers all over the world a uniform way to study how NNMT works. The information gained from using it adds to what is known about metabolism and helps with the development of possible treatment plans.
Researchers in the future will use this compound's abilities to answer more unanswered questions about how metabolic diseases start, how cells age, and how metabolic control works. It is still very important for progress to be made in this rapidly changing area that high-quality study materials are always available.
FAQ
1. What makes the 5 amino 1mq peptide specific for NNMT inhibition?
+
-
The quinoline-based chemical structure of the 5 amino 1mq peptide makes it very selective for the active site of the NNMT enzyme. This structural specialisation keeps interactions with other methyltransferases and cellular proteins to a minimum. This makes it possible for researchers to be sure that the effects they see are caused by blocking NNMT. Comprehensive enzyme screening panels and cellular activity profiling studies have shown that selectivity is real.
2. How do researchers typically use this compound in cell culture experiments?
+
-
To make stock solutions, scientists dissolve the substance in the right solvents. These solutions are then diluted to usable concentrations that are usually between 10 and 50 μM for cell culture uses. Depending on the research goals, cells are treated at certain times during differentiation protocols for adipogenesis studies or as acute treatments for immediate metabolic assessments. To find the best treatment parameters, researchers use vehicle controls and dose-response experiments.
3. Why has NNMT inhibition become an important research area?
+
-
NNMT transcript goes up in people who are overweight, have metabolic syndrome, are getting older, and have a number of diseases, which suggests that it has a functional role in these conditions. The enzyme's main job in NAD+ metabolism and epigenetic regulation makes it a central player in cellular energy balance and longevity, which is why it is a major focus of modern research.
Partner With BLOOM TECH as Your Trusted 5 amino 1mq Peptide Supplier
BLOOM TECH stands as your reliable research partner for high-purity metabolic research compounds. Our GMP-certified production facilities, validated by US-FDA, EU, and Japanese regulatory authorities, ensure pharmaceutical-grade quality for your critical experiments. We supply 5 amino 1mq peptide with comprehensive analytical documentation, including HPLC, mass spectrometry, and purity verification exceeding 98%.
Our experienced technical team provides detailed product information, handling recommendations, and application support throughout your research projects. With over 12 years in organic synthesis and pharmaceutical intermediate supply, we understand researchers' requirements for consistency, documentation, and reliable supply chains. Whether you need milligram quantities for initial screening or bulk amounts for extensive studies, our scalable production meets your specifications.
As a qualified 5 amino 1mq peptide supplier to international pharmaceutical companies and research institutions, we maintain strict quality control protocols and transparent pricing structures. Contact our team at Sales@bloomtechz.com to discuss your research requirements, request certificates of analysis, or obtain technical support for your metabolic enzyme research programs.
References
1. Kraus D, Yang Q, Kong D, Banks AS, Zhang L, Rodgers JT, Pirinen E, Pulinilkunnil TC, Gong F, Wang YC, Cen Y, Sauve AA, Asara JM, Peroni OD, Monia BP, Bhanot S, Alhonen L, Puigserver P, Kahn BB. Nicotinamide N-methyltransferase knockdown protects against diet-induced obesity. Nature. 2014;508(7495):258-262.
2. Ulanovskaya OA, Zuhl AM, Cravatt BF. NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nature Chemical Biology. 2013;9(5):300-306.
3. Komatsu M, Kanda T, Urai H, Kurokochi A, Kitahama R, Shigaki S, Ono T, Yukioka H, Hasegawa K, Tokuyama H, Kawabe Y, Wakino S. NNMT activation can contribute to the development of fatty liver disease by modulating the NAD+ metabolism. Scientific Reports. 2018;8(1):8637.
4. Neelakantan H, Vance V, Wetzel MD, Wang HL, McHardy SF, Finnerty CC, Hommel JD, Watowich SJ. Selective and membrane-permeable small molecule inhibitors of nicotinamide N-methyltransferase reverse high-fat diet-induced obesity in mice. Biochemical Pharmacology. 2018;147:141-152.
5. Hong S, Moreno-Navarrete JM, Wei X, Kikukawa Y, Tzameli I, Prasad D, Lee Y, Asara JM, Fernández-Real JM, Maratos-Flier E, Pissios P. Nicotinamide N-methyltransferase regulates hepatic nutrient metabolism through Sirt1 protein stabilization. Nature Medicine. 2015;21(8):887-894.
6. Brachs S, Polack J, Brachs M, Jahn-Hofmann K, Elvert R, Pfenninger A, Bärenz F, Margerie D, Mai K, Spranger J, Kannt A. Genetic nicotinamide N-methyltransferase (Nnmt) deficiency in male mice improves insulin sensitivity in diet-induced obesity but does not affect glucose tolerance. Diabetes. 2019;68(3):527-542.
